US Stock MarketDetailed Quotes

ASND Ascendis Pharma A/S

Watchlist
  • 138.375
  • +0.195+0.14%
Trading Mar 11 09:35 ET
8.28BMarket Cap-19.56P/E (TTM)

Ascendis Pharma A/S Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Ascendis Pharma A/S Q4 2024 Earnings Date

Currency：EURFeb 12, 2025

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
119.60M
173.92M
+54.32M
Beat Est.
-13.15%
+26.30%
+45.42%
EPS
-1.17
-0.64
+0.53
Beat Est.
+23.96%
+58.44%
+45.35%
Analyst Rating
Strong Buy

Feb 28, 2025

Ascendis Pharma A/S Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 11 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: EUR

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 125.611M--
--2025/Q1-- / 93.986M--
Feb 12, 20252024/Q4173.916M / 119.596M--
Nov 14, 20242024/Q357.833M / 70.312M--
Sep 3, 20242024/Q235.998M / 84.468M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 125.611M--
--2025/Q1-- / 93.986M--
Feb 12, 20252024/Q4173.916M / 119.596M--
Nov 14, 20242024/Q357.833M / 70.312M--
Sep 3, 20242024/Q235.998M / 84.468M--

Unlock Free Earnings Estimates

Ascendis Pharma A/S Earnings Reports

  • Ascendis Pharma A/S | 20-F: FY2024 Annual Report

    Feb 12 16:23 ET

  • Ascendis Pharma A/S | 6-K: Report of foreign private issuer (related to financial reporting)

    Feb 12 16:12 ET

  • Ascendis Pharma A/S | 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 14, 2024 16:59 ET

  • Ascendis Pharma A/S | 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 14, 2024 16:23 ET

    • Read more

    Trending Stocks

    Market Hot Picks Market Hot Picks
    No. Symbol Price
    Tesla
    TSLA
    222.150
    NVIDIA
    NVDA
    106.980
    Palantir
    PLTR
    76.380
    4
    Apple
    AAPL
    227.480
    5
    Strategy
    MSTR
    239.270
    Log In for the Full List
    Unlock Now